Tension	Tension	NN	B-NP	O
and	and	CC	O	O
phosphatidyl	phosphatidyl	JJ	B-NP	O
inositol	inositol	NN	I-NP	O
(	(	(	O	O
PI	PI	NN	B-NP	O
)	)	)	O	O
turnover	turnover	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
were	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
receptors	receptor	NNS	I-NP	O
and	and	CC	I-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
contractions	contraction	NNS	B-NP	O
elicited	elicit	VBN	B-VP	O
by	by	IN	B-PP	O
endothelin	endothelin	NN	B-NP	B-protein
(	(	(	O	I-protein
ET	ET	NN	B-NP	I-protein
)	)	)	O	I-protein
ligands	ligand	NNS	B-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
bronchus	bronchus	NN	I-NP	O
.	.	.	O	O

Nicardipine	Nicardipine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
L-type	L-type	JJ	I-NP	O
calcium	calcium	NN	I-NP	O
channel	channel	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
incubation	incubation	NN	B-NP	O
in	in	IN	B-PP	O
Ca2+-free	Ca2+-free	JJ	B-NP	O
medium	medium	NN	I-NP	O
,	,	,	O	O
produced	produce	VBD	B-VP	O
marked	marked	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
contractions	contraction	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ET	ET	NN	I-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
)	)	)	O	O
receptor-selective	receptor-selective	JJ	B-NP	O
agonist	agonist	NN	I-NP	O
,	,	,	O	O
sarafotoxin	sarafotoxin	NN	B-NP	O
S6c	S6c	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
especially	especially	RB	B-ADVP	O
those	those	DT	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
KCl	KCl	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
Ca2+-free	Ca2+-free	JJ	B-NP	O
medium	medium	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
appreciable	appreciable	JJ	B-NP	O
effect	effect	NN	I-NP	O
against	against	IN	B-PP	O
contraction	contraction	NN	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
endothelin-1	endothelin-1	NN	B-NP	B-protein
(	(	(	O	O
ET-1	ET-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
non-selective	non-selective	JJ	I-NP	O
ET	ET	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
ET	ET	NN	B-NP	B-protein
(	(	(	O	I-protein
B	B	NN	B-NP	I-protein
)	)	)	O	I-protein
receptor	receptor	NN	B-NP	I-protein
agonist	agonist	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Ca2+-free	Ca2+-free	JJ	B-NP	O
medium	medium	NN	I-NP	O
,	,	,	O	O
ryanodine	ryanodine	NN	B-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
intracellular	intracellular	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
mobilization	mobilization	NN	I-NP	O
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
sarafotoxin	sarafotoxin	NN	B-NP	O
S6c-	S6c-	NN	I-NP	O
and	and	CC	O	O
ET-1-induced	ET-1-induced	JJ	B-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
effect	effect	NN	B-NP	O
on	on	IN	B-PP	O
responses	response	NNS	B-NP	O
to	to	TO	B-PP	O
KCl	KCl	NN	B-NP	B-protein
.	.	.	O	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
nickel	nickel	NN	B-NP	O
chloride	chloride	NN	I-NP	O
(	(	(	O	O
Ni2+	Ni2+	JJ	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
mM	mM	NN	I-NP	O
)	)	)	O	O
caused	cause	VBD	B-VP	O
marked	marked	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
contractions	contraction	NNS	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
sarafotoxin	sarafotoxin	NN	B-NP	O
S6c	S6c	NN	I-NP	O
or	or	CC	I-NP	O
ET-1	ET-1	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
KCI	KCI	NN	B-NP	O
concentration-response	concentration-response	JJ	I-NP	O
curves	curve	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mixed	mixed	JJ	I-NP	O
ET	ET	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
/ET	/ET	NN	B-NP	B-protein
(	(	(	O	I-protein
B	B	NN	B-NP	I-protein
)	)	)	O	I-protein
receptor	receptor	NN	B-NP	I-protein
antagonist	antagonist	NN	I-NP	O
SB	SB	NN	I-NP	O
209670	209670	CD	I-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
inhibited	inhibit	VBD	B-VP	O
responses	response	NNS	B-NP	O
to	to	TO	B-PP	O
sarafotoxin	sarafotoxin	NN	B-NP	O
S6c	S6c	NN	I-NP	O
and	and	CC	I-NP	O
ET-1	ET-1	NN	I-NP	B-protein
such	such	JJ	B-NP	O
that	that	IN	I-NP	O
concentration-response	concentration-response	JJ	B-NP	O
curves	curve	NNS	I-NP	O
were	be	VBD	B-VP	O
shifted	shift	VBN	I-VP	O
rightward	rightward	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
maximum	maximum	NN	I-NP	O
response	response	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

0-	0-	CD	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

8-fold	8-fold	RB	B-ADVP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
whereas	whereas	IN	O	O
BQ-123	BQ-123	NN	B-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
ET	ET	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
receptor	receptor	NN	B-NP	O
antagonist	antagonist	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
effect	effect	NN	B-NP	O
on	on	IN	B-PP	O
response	response	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
either	either	DT	B-NP	O
agonist	agonist	NN	I-NP	O
.	.	.	O	O

ET-1	ET-1	NN	B-NP	B-protein
(	(	(	O	O
1	1	CD	B-NP	O
nM-0	nM-0	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
concentration-dependent	concentration-dependent	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
PI	PI	NN	B-NP	O
turnover	turnover	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
sarafotoxin	sarafotoxin	NN	B-NP	O
S6c	S6c	NN	I-NP	O
(	(	(	O	O
0	0	CD	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
nM-0	nM-0	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
induced	induce	VBD	B-VP	O
only	only	RB	B-NP	O
small	small	JJ	I-NP	O
and	and	CC	I-NP	O
variable	variable	JJ	I-NP	O
increases	increase	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
PI	PI	NN	B-NP	O
turnover	turnover	NN	I-NP	O
evoked	evoke	VBN	B-VP	O
by	by	IN	B-PP	O
ET-1	ET-1	NN	B-NP	B-protein
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
SB	SB	NN	B-NP	O
209670	209670	CD	I-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
by	by	IN	B-PP	O
BQ-123	BQ-123	NN	B-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
microM	microM	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
linkage	linkage	NN	B-NP	O
of	of	IN	B-PP	O
ET	ET	NN	B-NP	B-protein
(	(	(	O	I-protein
A	A	NN	B-NP	I-protein
)	)	)	O	I-protein
receptors	receptor	NNS	B-NP	I-protein
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
inositol	inositol	NN	B-NP	O
phosphate	phosphate	NN	I-NP	O
generation	generation	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
bronchial	bronchial	JJ	I-NP	I-cell_type
smooth	smooth	JJ	I-NP	I-cell_type
muscle	muscle	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
differences	difference	NNS	B-NP	O
exist	exist	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
contributions	contribution	NNS	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
and	and	CC	I-NP	O
extracellular	extracellular	JJ	I-NP	O
Ca2+	Ca2+	NN	I-NP	O
mobilization	mobilization	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
elicited	elicit	VBN	B-VP	O
by	by	IN	B-PP	O
ET	ET	NN	B-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
ET	ET	NN	B-NP	B-protein
(	(	(	O	I-protein
B	B	NN	B-NP	I-protein
)	)	)	O	I-protein
receptor	receptor	NN	B-NP	I-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
sarafotoxin	sarafotoxin	NN	B-NP	O
S6c-induced	S6c-induced	JJ	I-NP	O
,	,	,	O	O
ET	ET	NN	B-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
)	)	)	O	O
receptor-mediated	receptor-mediated	JJ	B-NP	O
contraction	contraction	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
bronchial	bronchial	JJ	I-NP	O
smooth	smooth	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dependent	dependent	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
upon	upon	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	O
Ca2+	Ca2+	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O

was	be	VBD	B-VP	O
also	also	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
Ca2+	Ca2+	NN	I-NP	O
release	release	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
from	from	IN	B-PP	O
ryanodine-sensitive	ryanodine-sensitive	JJ	B-NP	B-DNA
stores	store	NNS	I-NP	I-DNA
.	.	.	O	O

ET	ET	NN	B-NP	O
(	(	(	I-NP	O
A	A	NN	I-NP	O
)	)	)	I-NP	O
receptor-mediated	receptor-mediated	JJ	I-NP	O
contraction	contraction	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
airway	airway	NN	I-NP	O
smooth	smooth	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
largely	largely	RB	B-ADVP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
Ca2+	Ca2+	NN	I-NP	O
.	.	.	O	O

